Director TitleAgeSince
Chairman - -
Chairman - 27/06/2012
Director/Board Member - 23/12/2012
Change 5-day change 1-year change 3-year change Capi.($)
+1.25%-20.59% - - 23.15M
+0.21%-7.67%+61.07%+71.32% 68.92B
+1.82%+7.62%+8.24%+61.57% 51.9B
+3.21%+7.28%+12.59%+41.84% 48.73B
+2.35%+3.53%+31.95%+34.69% 43.13B
-0.29%+2.93%+290.72%+467.53% 41.48B
+5.20%+6.04%+17.44%+113.46% 39.96B
+1.28%-0.76%+12.67%+45.10% 30.6B
-2.21%-14.22%+40.33%-0.94% 26.01B
+1.95%-2.26%-13.76%-7.21% 22.27B
Average +1.44%-3.90%+51.25%+91.93% 41.44B
Weighted average by Cap. +1.54%-3.49%+55.00%+98.57%
Logo Pharmadax Inc.
Pharmadax Inc is a Taiwan-based company principally engaged in the development, licensing and sales of Abbreviated New Drug Application (ANDA) drugs. The Company is mainly engaged in the development of oral solid extended-release dosage forms and products. The Company's main product is the hypoglycemic product, Glyburide. The Company distributes its products to the United States.
Employees
-
  1. Stock Market
  2. Stocks
  3. 4191 Stock